US Patent Issued to ETH Zurich on Feb. 24 for "Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy" (Swiss Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,525, issued on Feb. 24, was assigned to ETH Zurich (Zurich, Switzerland).

"Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy" was invented by Viola Vogel (Zurich, Switzerland), Mamta Chabria (Zurich, Switzerland), Giulia Valpreda (Forschungsstrasse, Switzerland), Belinda Trachsel (Forschungsstrasse, Switzerland) and Martin Behe (Forschungsstrasse, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to fibronectin-binding peptides according to the sequence FnI5BS-L1-FnI4BS-L2-FnI3BS-L3-FnI2BSwhich are useful in tumor or fibrosis diagnosis and therapy. Instant peptides show ...